Which factors predict patient satisfaction with botulinum toxin treatment for cervical dystonia?
Objective: Investigate which factors influence patient satisfaction with botulinum neurotoxin type A (BoNT-A) treatment for cervical dystonia (CD) in routine practice. Background: We have previously…Clinical and demographics of cervical dystonia related to the direction of the neck movement
Objective: The objectives of this report is to survey whether the type of torticollis (i.e. rotation, retrocolis and anterocolis) is related to the clinical characteristics…Clinical effects are persistent at the end of one abobotulinumtoxinA injection cycle in cervical dystonia – results from a meta-analysis of 1091 subjects
Objective: Evaluate the impact of one injection cycle of abobotulinumtoxinA (AboBoNT-A; Dysport®) on the clinical characteristics of cervical dystonia (CD). Background: The pharmacologic effects of…Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study
Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the…Oromandibular dystonia (OMD): A Prospective, Single-Blind Trial of AbobotulinumtoxinA (AboA)
Objective: To examine the safety and efficacy of AboA in OMD Background: OMD causes involuntary movements of the lower facial, masticatory, and lingual muscles. The…Dystonia treatment in an international cohort: a longitudinal analysis
Objective: To assess the change in therapy for dystonia over time Background: Although botulinum toxin (BoNT) injections are the gold standard therapy for patients with focal…Clinical profile of patients with blepharospasm
Objective: To present the clinical profile of 61 patients with blepharospasm who were treated with onabotulinum toxin injections. Background: Blepharospasm is a focal dystonia that…Clinical analysis of patients with servical dystonia who Botulinum toxin injection is performed: 10 years experience of Ege University Neurology Department of Movement Disorders Clinic
Objective: In this study, it is aimed to analysis of clinical features and treatment efficiency in patients with servical dystonia who are performed Botulinum injection…Epidemiological profile and challenges of a reference public center for the treatment of neurological conditions using botulinum toxin type A: experience of a North-eastern center in Brazil.
Objective: To identify the epidemiological profile of patients treated with botulinum toxin type A (BTA) in a tertiary clinic in Brazil. Background: BTA is used to…Antibody-Induced Failure of Botulinum Toxin Therapy: Restart with Incobotulinumtoxina Offers a New Opportunity
Objective: To study whether incobotulinumtoxinA (INCO), a new, low-antigenicity botulinum toxin (BT) drug, increases BT antibody (BTAB) titers in patients with antibody-induced therapy failure (ABTF)…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- 19
- Next Page »